Regulation

How Will White House AI Plan Transform Healthcare Now?
Technology How Will White House AI Plan Transform Healthcare Now?

What if the key to solving healthcare's toughest challenges—faster drug development, precise patient care, and streamlined regulations—lies not in a hospital or lab, but in artificial intelligence? In 2025, this isn't a distant dream but a pressing reality, as the White House's AI Act

How Did a Data Breach Impact 171,800 at Doctors Imaging?
Data and Information How Did a Data Breach Impact 171,800 at Doctors Imaging?

Setting the Stage for a Healthcare Cybersecurity Crisis Imagine a scenario where a single breach of digital security exposes the most intimate details of over 171,800 lives—names, medical histories, and financial records laid bare to malicious actors, creating a profound crisis in trust and safety.

Clinical Trials Evolve with Tech and Diversity Focus
Data and Information Clinical Trials Evolve with Tech and Diversity Focus

Overview of the Clinical Trial Industry Imagine a world where life-saving drugs reach patients faster, powered by cutting-edge technology and a relentless focus on diversity in research. This is the reality of the clinical trial industry today, a cornerstone of pharmaceutical and biotech

Pro-Life Advocates Slam FDA Over Abortion Drug Approval
Public Policy Pro-Life Advocates Slam FDA Over Abortion Drug Approval

Overview of the Current Debate In a landscape where abortion policy remains one of the most divisive issues in American healthcare, the recent approval by the Food and Drug Administration (FDA) of a generic version of mifepristone—a drug central to over 60% of chemical abortions in the U.S.—has ign

Dr. Schroer Urges Overhaul of Medicaid and U.S. Healthcare
Public Policy Dr. Schroer Urges Overhaul of Medicaid and U.S. Healthcare

Introduction to the Crisis in American Healthcare Imagine a system where millions struggle to afford basic medical care, despite the United States spending more on healthcare per capita than any other nation, revealing a stark reality of staggering costs and complex bureaucratic structures. This

FDA Launches Pilot for Faster Generic Drug Review in U.S.
Public Policy FDA Launches Pilot for Faster Generic Drug Review in U.S.

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with deep expertise in medical technology and manufacturing. With years of experience in the production of diagnostic and treatment devices, Faisal has a unique perspective on the evolving landscape of pharmaceutical

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later